Centre Hospitalier Intercommunal Creteil   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Creteil France (1937)

Organization Overview

First Clinical Trial
2010
NCT01448018
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Centre Hospitalier Intercommunal Créteil | Centre Hospitalier Intercommunal Creteil | Centre Hospitalier Intersommunal de Créteil | CHI Creteil | CHI Créteil | CRC CHI Creteil France | Creteil Hospital Center | Creteil Hospital center (CHIC) | Dr Massin Nathalie | Service de pneumologie, CH intercommunal de Créteil | Virginie ESCABASSE

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Abruptio Placentae (Phase 3)

Adenocarcinoma (Phase 3)

Adenocarcinoma of Lung (Phase 3)

Anemia, Sickle Cell (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Cystic Fibrosis (Phase 3)

Eclampsia (Phase 3)

Eye Diseases (Phase 3)

Fetal Growth Retardation (Phase 3)

Fibrosis (Phase 3)

Hypertension (Phase 3)

Infertility (Phase 3)

Lung Diseases (Phase 3)

Lung Neoplasms (Phase 3)

Macular Degeneration (Phase 3)

Neoplasm Metastasis (Phase 3)

Perinatal Death (Phase 3)

Pneumonia (Phase 2)

Pre-Eclampsia (Phase 3)

Pregnancy Complications (Phase 3)

Retinal Degeneration (Phase 3)

Retinal Diseases (Phase 3)

Retinal Vein Occlusion (Phase 4)

Sinusitis (Phase 3)

Wet Macular Degeneration (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 20
  • # of Trial APIs: 34